Shachi Patel, MD
Pain Medicine · Newark, DENPI 1285994582
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 90.5% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $16,521 and has fallen 98.9% since, to $176 in 2025. Among pain medicine clinicians in DE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $154.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$24K
- Vertiflex, Inc.$1K
- Nevro Corp.$471
- Vertos Medical, Inc.$214
- Averitas Pharma Inc.$164
- Medtronic$83
- plus $410 from 10 others
What the payments were for
- Consulting fees$9,61036%
- Speaking & faculty fees$7,11027%
- Travel & lodging$5,05619%
- Food & beverage$4,95219%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 119 | $24,181 |
| Vertiflex, Inc. | 6 | $1,205 |
| Nevro Corp. | 14 | $471 |
| Vertos Medical, Inc. | 8 | $214 |
| Averitas Pharma Inc. | 6 | $164 |
| Medtronic | 4 | $83 |
| Scilex Pharmaceuticals Inc. | 4 | $80 |
| Boston Scientific | 2 | $70 |
| SPR Therapeutics, Inc | 1 | $58 |
| Octapharma USA, Inc. | 1 | $45 |
| Nalu Medical, Inc. | 2 | $36 |
| MML US, Inc. | 1 | $29 |
| Fidia Pharma USA Inc. | 2 | $29 |
| Pacira Therapeutics, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Neuromodulation Dspsbls and Accs$15,359
- PROCLAIM$2,873
- Proclaim IPG$2,410
- Proclaim Family of SCS IPGs$1,423
- Superion ISS$1,092
- Senza Spinal Cord Stimulation System$133
How this compares
$26,728 in reported general payments places this provider in the 90th percentile of 31 pain medicine providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 14 | $1,653 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $855 |
| Gabapentin | 51 | $788 |
| Celecoxib | 20 | $749 |
| Pregabalin | 44 | $625 |
| Tizanidine Hcl | 24 | $329 |
| Tramadol Hcl | 44 | $307 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $224 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Newark
- Hersh PatelNewark$104K
- James DowningNewark$2K
- Nancy KimNewark$1K
- Rany AbdallahBear$291K
- Selina XingWilmington$13K
- Manonmani AntonyGeorgetown$11K
- Andrew CrichlowGeorgetown$7K
- Phong leMilford$7K
- Alexander MatzWilmington$6K
- Daniel NasrWilmington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.